375 related articles for article (PubMed ID: 10768569)
1. Considerations in the selection of radiopharmaceuticals for palliation of bone pain from metastatic osseous lesions.
Bouchet LG; Bolch WE; Goddu SM; Howell RW; Rao DV
J Nucl Med; 2000 Apr; 41(4):682-7. PubMed ID: 10768569
[TBL] [Abstract][Full Text] [Related]
2. Marrow toxicity of 33P-versus 32P-orthophosphate: implications for therapy of bone pain and bone metastases.
Goddu SM; Bishayee A; Bouchet LG; Bolch WE; Rao DV; Howell RW
J Nucl Med; 2000 May; 41(5):941-51. PubMed ID: 10809212
[TBL] [Abstract][Full Text] [Related]
3. Marrow-sparing effects of 117mSn(4+)diethylenetriaminepentaacetic acid for radionuclide therapy of bone cancer.
Bishayee A; Rao DV; Srivastava SC; Bouchet LG; Bolch WE; Howell RW
J Nucl Med; 2000 Dec; 41(12):2043-50. PubMed ID: 11138691
[TBL] [Abstract][Full Text] [Related]
4. S values for radionuclides localized within the skeleton.
Bouchet LG; Bolch WE; Howell RW; Rao DV
J Nucl Med; 2000 Jan; 41(1):189-212. PubMed ID: 10647623
[TBL] [Abstract][Full Text] [Related]
5. Relative efficacy of 32P and 89Sr in palliation in skeletal metastases.
Nair N
J Nucl Med; 1999 Feb; 40(2):256-61. PubMed ID: 10025832
[TBL] [Abstract][Full Text] [Related]
6. Radiopharmaceutical therapy for palliation of bone pain from osseous metastases.
Pandit-Taskar N; Batraki M; Divgi CR
J Nucl Med; 2004 Aug; 45(8):1358-65. PubMed ID: 15299062
[TBL] [Abstract][Full Text] [Related]
7. [Radioprotection and environmental pollution by the use of the radionuclides 89Sr, 186Re, and 153Sm for pain palliation in metastatic bone diseases. Related calculations].
Sbonias E
Hell J Nucl Med; 2005; 8(2):68-73. PubMed ID: 16142246
[TBL] [Abstract][Full Text] [Related]
8. Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group.
Brundage MD; Crook JM; Lukka H
Cancer Prev Control; 1998 Apr; 2(2):79-87. PubMed ID: 9765768
[TBL] [Abstract][Full Text] [Related]
9. Teletherapy and radiopharmaceutical therapy of painful bone metastases.
Silberstein EB
Semin Nucl Med; 2005 Apr; 35(2):152-8. PubMed ID: 15765378
[TBL] [Abstract][Full Text] [Related]
10. [Use of radionuclides in therapy].
Vucina J; Han R
Med Pregl; 2001; 54(5-6):245-50. PubMed ID: 11759220
[TBL] [Abstract][Full Text] [Related]
11. 186Re-etidronate. Efficacy of palliative radionuclide therapy for painful bone metastases.
Han SH; De Klerk JM; Zonnenberg BA; Tan S; Van Rijk PP
Q J Nucl Med; 2001 Mar; 45(1):84-90. PubMed ID: 11456380
[TBL] [Abstract][Full Text] [Related]
12. Internal radiotherapy of painful bone metastases.
Liepe K; Kotzerke J
Methods; 2011 Nov; 55(3):258-70. PubMed ID: 21803158
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of 188Re-HEDP, 186Re-HEDP, 153Sm-EDTMP and 89Sr in the treatment of painful skeletal metastases.
Liepe K; Kotzerke J
Nucl Med Commun; 2007 Aug; 28(8):623-30. PubMed ID: 17625384
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.
Uusijärvi H; Bernhardt P; Ericsson T; Forssell-Aronsson E
Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220
[TBL] [Abstract][Full Text] [Related]
15. Radiopharmaceuticals for bone lesions. Imaging and therapy in clinical practice.
Pauwels EK; Stokkel MP
Q J Nucl Med; 2001 Mar; 45(1):18-26. PubMed ID: 11456371
[TBL] [Abstract][Full Text] [Related]
16. An assessment of bone-seeking radionuclides for palliation of metastatic bone pain in a vertebral model.
Sadremomtaz A; Masoumi M
Ann Nucl Med; 2019 Apr; 33(4):252-264. PubMed ID: 30659480
[TBL] [Abstract][Full Text] [Related]
17. Comparative studies on the potential use of
Zakaly HMH; Mostafa MYA; Deryabina D; Zhukovsky M
Int J Radiat Biol; 2020 Jun; 96(6):779-789. PubMed ID: 32043915
[No Abstract] [Full Text] [Related]
18. The use of radioisotopes for palliation of metastatic bone pain.
Gkialas I; Iordanidou L; Galanakis I; Giannopoulos S
J BUON; 2008; 13(2):177-83. PubMed ID: 18555462
[TBL] [Abstract][Full Text] [Related]
19. Radiopharmaceuticals in clinical trials.
Holmes RA
Semin Oncol; 1993 Jun; 20(3 Suppl 2):22-6. PubMed ID: 7684861
[TBL] [Abstract][Full Text] [Related]
20. [Palliative treatment of bone metastases with bone-seeking radionuclides].
De Klerk JM; Zonnenberg BA; Huiskes AW; Han SH; Blijham GH; Van Rijk PP
Ned Tijdschr Geneeskd; 1998 Nov; 142(48):2618-22. PubMed ID: 10028362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
